T43.012 Poisoning by tricyclic antidepressants, intentional self-harm

Name of the Condition

• Poisoning by tricyclic antidepressants, intentional self-harm
• Technical term: T43.012

Summary

This code describes intentional self-harm resulting from tricyclic antidepressant poisoning. Tricyclic antidepressants (TCAs) are a class of medications used to treat depression and other mental health conditions. The code applies when clinical documentation confirms an intentional overdose event, distinguishing it from accidental or therapeutic adverse effects.

Causes

Intentional self-harm may result from deliberate ingestion of excessive TCA doses, often associated with suicidal ideation or attempts. It can occur due to access to unsecured medication, impulsive behavior, or a desire to self-harm. Documentation must clearly indicate intent for this code to be applied.

Risk Factors

• History of suicidal ideation or previous self-harm attempts.
• Concurrent mental health conditions (e.g., depression, anxiety).
• Access to tricyclic antidepressants without supervision.
• Social or environmental stressors contributing to emotional distress.

Symptoms

Symptoms of tricyclic antidepressant poisoning can include:

• Excessive drowsiness, confusion, or coma.
• Rapid heart rate, irregular heartbeat, or cardiac arrest.
• Seizures, tremors, or muscle rigidity.
• Dry mouth, blurred vision, or urinary retention.
• Nausea, vomiting, or abdominal pain.

Diagnosis

Diagnosis requires clinical evaluation, including a detailed history of medication use and intent. Laboratory tests (e.g., drug levels) may confirm TCA exposure. Documentation must explicitly state intentional self-harm to support this code. Physical exam findings (e.g., cardiac abnormalities, neurological symptoms) and patient history are critical.

Treatment Options

Treatment focuses on stabilizing the patient, including airway management, cardiac monitoring, and supportive care. Activated charcoal may reduce absorption if administered early. Specific antidotes (e.g., sodium bicarbonate) address cardiac toxicity. Psychiatric evaluation and intervention are essential for ongoing care.

Prognosis and Follow-Up

Prognosis depends on the dose ingested, time to treatment, and patient response. Early intervention improves outcomes. Follow-up includes psychiatric assessment, medication management, and safety planning to reduce future risk. Long-term monitoring for recurrence or complications is recommended.

Complications

Complications may include cardiac arrhythmias, seizures, respiratory depression, or multi-organ failure. Delayed treatment increases risk of severe outcomes. Psychological sequelae, such as depression or anxiety, may persist and require ongoing support.

Lifestyle & Prevention

Prevention involves secure medication storage, patient education on proper dosing, and access to mental health resources. Family or caregiver involvement in medication management can reduce risk. Regular psychiatric follow-up helps address underlying conditions contributing to self-harm.

When to Seek Professional Help

Seek immediate medical attention if intentional overdose is suspected or confirmed. Signs of toxicity (e.g., altered mental status, cardiac symptoms) require urgent care. Prompt evaluation by healthcare providers is critical to minimize harm and address underlying mental health needs.

Tips for Medical Coders

This code requires clear documentation of intentional self-harm. Ensure clinical notes specify the intent behind the overdose and confirm tricyclic antidepressant involvement. Avoid using this code for accidental or therapeutic adverse effects. Verify that the encounter aligns with the code’s definition to ensure accurate reporting.